Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29394125

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Apr 1
First author
Roemer MGM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Sep 1;36(25):2657. doi: 10.1200/JCO.2018.78.9826.
    note
    Source null
    related pmid
    29847290
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2018 Sep 1;36(25):2656. doi: 10.1200/JCO.2018.78.4116.
    note
    Source null
    related pmid
    29847295
    relationship
    Comment in

Authors and identifiers

  1. name
    Roemer MGM
    type
    Author
  2. name
    Redd RA
    type
    Author
  3. name
    Cader FZ
    type
    Author
  4. name
    Pak CJ
    type
    Author
  5. name
    Abdelrahman S
    type
    Author
  6. name
    Ouyang J
    type
    Author
  7. name
    Sasse S
    type
    Author
  8. name
    Younes A
    type
    Author
  9. name
    Fanale M
    type
    Author
  10. name
    Santoro A
    type
    Author
  11. name
    Zinzani PL
    type
    Author
  12. name
    Timmerman J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Roemer MGM
    type
    Author
  2. name
    Redd RA
    type
    Author
  3. name
    Cader FZ
    type
    Author
  4. name
    Pak CJ
    type
    Author
  5. name
    Abdelrahman S
    type
    Author
  6. name
    Ouyang J
    type
    Author
  7. name
    Sasse S
    type
    Author
  8. name
    Younes A
    type
    Author
  9. name
    Fanale M
    type
    Author
  10. name
    Santoro A
    type
    Author
  11. name
    Zinzani PL
    type
    Author
  12. name
    Timmerman J
    type
    Author
bibliography ids
  1. nci-bib-f7187b6b615cc74d159b4d48
book metadata
content sha256
6d5db822178f1f80ec769f810c485a8120a2bf3239c46c1ca4cdfa3c6ca65992
document type
citation
dois
  1. 10.1200/JCO.2017.77.3994
electronic publication date
display
2018 Feb 2
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29394125
immutable id
pubmed:29394125@6d5db822178f1f80ec769f810c485a8120a2bf3239c46c1ca4cdfa3c6ca65992
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
10
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
942-950
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Sep 1;36(25):2657. doi: 10.1200/JCO.2018.78.9826.
    note
    Source null
    related pmid
    29847290
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2018 Sep 1;36(25):2656. doi: 10.1200/JCO.2018.78.4116.
    note
    Source null
    related pmid
    29847295
    relationship
    Comment in
outcomes validated
false
pmid
29394125
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
4b5a2dfaaa832d16d64cf554064d0729ed4cc244723ebd71acbc67a63db88821
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Apr 1
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29394125/
title
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice